VERU INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
VERU INC. (VERU) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 190.00 thousand shares for the 12-month period ending 2017-09-30, per its 10-K filed 2018-01-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2018-01-02
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2013-09-30 was -777.43K shares.
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2013-06-30 was 14.93K shares.
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2013-03-31 was 0.00 shares.
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2012-12-31 was 827.18K shares.
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 190.00K shares, a 87.65% increase from fiscal 2016.
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2016 was 101.25K shares, a 65.50% decline from fiscal 2015.
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2015 was 293.50K shares, a 37.42% increase from fiscal 2014.
- VERU INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2014 was 213.58K shares, a 230.22% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 24 month |
|---|---|---|---|---|---|
| 2017-09-30 | 190.00K shares 10-K · filed 2018-01-02 | ||||
| 2016-09-30 | 101.25K shares 10-K · filed 2018-01-02 | ||||
| 2015-09-30 | 293.50K shares 10-K · filed 2018-01-02 | ||||
| 2014-09-30 | 213.58K shares 10-K · filed 2016-12-12 | ||||
| 2013-09-30 | -777.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | -762.51K shares derived: sum of 2 quarters · filed 2015-12-02 | -762.51K shares derived: sum of 3 quarters · filed 2015-12-02 | 64.68K shares 10-K · filed 2015-12-02 | |
| 2013-06-30 | 14.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | 14.93K shares derived: sum of 2 quarters · filed 2013-08-01 | 842.11K shares 10-Q · filed 2013-08-01 | 132.68K shares derived: sum of 4 quarters · filed 2014-12-02 | |
| 2013-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | 827.18K shares 10-Q · filed 2013-05-02 | 117.75K shares derived: sum of 3 quarters · filed 2014-12-02 | ||
| 2012-12-31 | 827.18K shares 10-Q · filed 2013-01-30 | 117.75K shares derived: sum of 2 quarters · filed 2014-12-02 | |||
| 2012-09-30 | -709.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | 52.50K shares 10-K · filed 2014-12-02 | 52.50K shares 10-K · filed 2013-12-03 | ||
| 2012-06-30 | 761.93K shares 10-Q · filed 2012-07-31 | ||||
| 2011-09-30 | 293.75K shares 10-K · filed 2013-12-03 | ||||
| 2010-09-30 | 35.25K shares 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |